Table 5.
TOP 10 KEGG enrichment of GSEA for DSEL.
Description | setSize | enrichmentScore | NES | pvalue | p.adjust |
---|---|---|---|---|---|
KEGG_ALLOGRAFT_REJECTION | 35 | −0.77705 | −3.26139 | 1.00E–10 | 2.61E–09 |
KEGG_AUTOIMMUNE_THYROID_DISEASE | 50 | −0.70576 | −3.23748 | 1.00E–10 | 2.61E–09 |
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION | 46 | −0.71065 | −3.19615 | 1.00E–10 | 2.61E–09 |
KEGG_PRIMARY_IMMUNODEFICIENCY | 35 | −0.73977 | −3.10493 | 1.00E–10 | 2.61E–09 |
KEGG_GRAFT_VERSUS_HOST_DISEASE | 37 | −0.72013 | −3.06925 | 1.00E–10 | 2.61E–09 |
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | 129 | −0.52359 | −2.91846 | 1.00E–10 | 2.61E–09 |
KEGG_HEMATOPOIETIC_CELL_LINEAGE | 84 | −0.54644 | −2.78867 | 1.00E–10 | 2.61E–09 |
KEGG_ECM_RECEPTOR_INTERACTION | 83 | 0.58285 | 2.227741 | 7.82E–10 | 1.79E–08 |
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 131 | −0.40807 | −2.29007 | 1.40E–09 | 2.84E–08 |